Download the Research Summary (PDF) Research Question What are risk factors for food insecurity among HIV-positive individuals receiving treatment in BC? Main Finding Participants who had low incomes, currently used illegal drugs and tobacco, or who had depressive symptoms were more likely to be food insecure. Full Article A. Anema, S.D. Weiser, K.A. Fernandes, E. […]
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (November 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (October 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (September 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (August 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (July 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (June 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (May 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (April 2010) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (March 2010) Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
